Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2010

01-02-2010 | Research Articles

Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study

Authors: Noemi Garrigós, Javier Gallego, Carmen Guillén-Ponce, Patricia Guaraz, Miriam García-Bautista, Adela Castillejo, Ángeles Gómez-Martínez, Alfredo Carrato, Álvaro Rodríguez-Lescure, José L. Soto

Published in: Clinical and Translational Oncology | Issue 2/2010

Login to get access
Metadata
Title
Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study
Authors
Noemi Garrigós
Javier Gallego
Carmen Guillén-Ponce
Patricia Guaraz
Miriam García-Bautista
Adela Castillejo
Ángeles Gómez-Martínez
Alfredo Carrato
Álvaro Rodríguez-Lescure
José L. Soto
Publication date
01-02-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/S12094-010-0479-7

Other articles of this Issue 2/2010

Clinical and Translational Oncology 2/2010 Go to the issue

Case Reports

Rectal metastasis from lobular breast carcinoma 15 years after primary diagnosis

Case Reports

Mixed paratesticular liposarcoma with osteosarcoma elements

News and Views

A summary in time

Educational Series

Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain

Educational Series

Gastrointestinal stromal tumours at present: an approach to burning questions

Editorial

The Purple Clinical Series: a useful tool for clinical oncologists to tackle current hot spots in cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits